Latest Blogs

Don S. Dizon, MD, FACP, FASCO
Aug 15, 2019
Oncologist, Dad, Social Media Proponent: How These Identities Shape a Worldview
Dr. Gil Morgan joins me in a conversation about how our perspectives have been enriched by work, parenthood, and online connections.
Nagi S. El Saghir, MD, FACP, FASCO
Aug 12, 2019
Best of ASCO Keeps Getting Better!
Over 400 attendees and exceptional international faculty members made the 2019 Best of ASCO Lebanon meeting a great success.
Women in Oncology
Aug 12, 2019
On Kindness and Gratitude: Reflections From the Other Side of Cancer
After a breast cancer diagnosis, cancer researcher Dr. Priscila Gonçalves went from "helper" to "helped." She discovered incredible kindness along the way.  
Howard A. Burris, MD, FASCO
Aug 09, 2019
Stronger Together: Uniting to Conquer Cancer Around the Globe
Planning for our first global meeting, ASCO Breakthrough: A Global Summit for Oncology Innovators, is almost complete.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO. Prior to this role, he served as Chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a Past President of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to the obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

May 20, 2019
The Impact of Utilization Management on Patients and Practices: A Conversation with Dr. Jeffery Ward
Dr. Ward and I discuss the policies that public and private insurers use to control the use of anticancer drug therapies, such as prior authorization requirements, restrictive formularies, step therapy, or fail first requirements, and specialty specific tiers.
Mar 26, 2019
Exclusive Interview: NCI Director Dr. Ned Sharpless Discusses the Future of Cancer Clinical Trials
Dr. Sharpless joined me to talk about pediatric cancer research, clinical trial methodology, eligibility criteria, and more.
Mar 11, 2019
Losing a Board Member: 5 Lessons From the Life of Dr. Arti Hurria
For many of us not a day has gone by without some reminder of Arti, but last week brought it all back into sharp focus as I was asked to talk about the role we at ASCO played in her career during a symposium in her honor.
Feb 07, 2019
Exclusive Interview: FDA Commissioner Dr. Scott Gottlieb Talks Drug Pricing, Expanded Access, and Tobacco Control
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as controlling the next generation of tobacco products.
Feb 01, 2019
Reflections on World Cancer Day 2019: The Challenge of “I Will”
What will each of us do, going forward, to further confront and reduce the global burden of cancer? For us at ASCO, the challenge will be answered through our mission pillars: education, research, and quality.
Jan 28, 2019
What You Need to Know About the Final 2019 Medicare Physician Fee Schedule and Quality Payment Program Rule
Editor’s note: Dr. Hudis hosts the ASCO in Action Podcast, which focuses on policy and practice issues affecting providers and patients. An excerpt of a recent episode is shared below; it has been edited for length and clarity.

Pages